Metraipolis › archive › dc_c72deec962d7
The Evolution, Current Landscape, and Future Prospects of Oncolytic Virotherapy in Melanoma: Talimogene Laherparepvec and Beyond — Europe PMC PMID:41148835
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41148835
- DOI
- 10.3390/cells14201620
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T05:58:28.796Z
- SHA-256 of the archived text
08f8deefd971c96c7ddf46e0da169b017a2db1b4090274eea9129c4fef05e741- Stable URL of this page
https://metraipolis.com/documento/dc_c72deec962d7
How to cite
The Evolution, Current Landscape, and Future Prospects of Oncolytic Virotherapy in Melanoma: Talimogene Laherparepvec and Beyond — Europe PMC PMID:41148835 — Europe PMC (en), https://europepmc.org/article/MED/41148835 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c72deec962d7 (Metraipolis archive dc_c72deec962d7, sha256 08f8deefd971c96c7ddf46e0da169b017a2db1b4090274eea9129c4fef05e741)
BibTeX
@misc{dcc72deec962d7,
title = {The Evolution, Current Landscape, and Future Prospects of Oncolytic Virotherapy in Melanoma: Talimogene Laherparepvec and Beyond — Europe PMC PMID:41148835},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41148835},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c72deec962d7; sha256 08f8deefd971c96c7ddf46e0da169b017a2db1b4090274eea9129c4fef05e741},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41148835. Agents can read the archived copy with the MCP tool read_document.